Nancy J. Hutson - 03 Oct 2023 Form 4 Insider Report for Clearside Biomedical, Inc. (CLSD)

Role
Director
Signature
/s/ Mark Ballantyne, Attorney-in-Fact
Issuer symbol
CLSD
Transactions as of
03 Oct 2023
Net transactions value
+$8,600
Form type
4
Filing time
04 Oct 2023, 17:06:34 UTC
Previous filing
23 Jun 2023
Next filing
22 May 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CLSD Common Stock Purchase $8,600 +10,000 +12% $0.8600 93,000 03 Oct 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.